Melatonin Protects Mitochondrial Function and Inhibits Oxidative Damage against the Decline of Human Oocytes Development Caused by Prolonged Cryopreservation

Cells. 2022 Dec 12;11(24):4018. doi: 10.3390/cells11244018.

Abstract

Melatonin (MT) can improve the effect of cryopreservation on oocytes by suppressing oxidative stress and maintaining the permeability of the oolemma. In this study, MT was firstly applied to human oocytes' cryopreservation to explore the effect of prolonged cryopreservation on developmental competence and its role. Collected in vitro-matured human oocytes were cryopreserved in MT-containing or MT-free medium for 0 and 6 months; after warming, viable oocytes were assessed for developmental viability, intracellular protein expression, mitochondrial function, and oxidation-antioxidant system. Meanwhile, fresh oocytes were set as the control. The results showed that with the extension of cryopreservation time, the developmental competence of oocytes gradually declined, accompanied by the down-regulation of most mitochondrial function-related proteins, the reduction in ATP and GSH production, the increase in ROS accumulation, and the aggravation of the imbalance of ROS/GSH in oocytes. However, the participation of MT seemed to effectively mitigate these negative effects. Therefore, we speculate that melatonin may maintain normal ATP production and ROS/GSH balance in cryopreserved oocytes by protecting mitochondrial function and inhibiting oxidative damage, thereby effectively maintaining the developmental competence of human oocytes in prolonged cryopreservation.

Keywords: development; human oocytes; melatonin; mitochondrial function; oxidative damage; prolonged cryopreservation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Cryopreservation / methods
  • Humans
  • Melatonin* / metabolism
  • Melatonin* / pharmacology
  • Mitochondria / metabolism
  • Oocytes / metabolism
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism

Substances

  • Melatonin
  • Reactive Oxygen Species
  • Adenosine Triphosphate

Grants and funding

This study was supported by National Natural Science Foundation of China (Zhiguo Zhang, No. 82071724; Huijuan Zou, No. 32000642, Beili Chen, No. 82001516 and Weiwei Zou, No. 82001635), National Key Research and Development Program of China (Yunxia Cao, Zhiguo Zhang, 2022YFC2703000), the Natural Science Foundation of the Anhui Higher Education Institution (Ding Ding, No. KJ2020A0202), the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (Yunxia Cao, No. 2019PT310002), the Research Fund of Anhui Institute of translational medicine (Yunxia Cao, No. ZHYX2020A001 and Huijuan Zou, No. 2021zhyx-B16).